Late Breaking News
BETHESDA, MD—Even drugs that have been on the market for years, sometimes decades, are not immune from reexamination and relabeling brought about by new scientific discoveries. In the field of pharmacogenomics especially, new opportunities are presenting themselves to use new science to improve drug safety and dosing protocols.
BETHESDA, MD—To help advance research on how genes affect responses to medicines, NIH is spending $15 million over five years to expand the Pharmacogenomics Knowledge Base (PharmGKB).
ROCKVILLE, MD—“One of the things the public has problems dealing with is uncertainty and building science around that uncertainty,” declared Jesse Goodman, MD, FDA’s science chief, at a recent meeting of the FDA Science Board.
WASHINGTON, DC—Navy patients in remote locations are expected to have greater access to pharmacists as a result of a telepharmacy system that the Navy is using.
WASHINGTON, DC—Receiving medications by mail rather than waiting in line for them is one of the benefits of a new pharmacy initiative piloted by IHS and VA.
WASHINGTON, DC—What does a pharmacist working in a VA hospital look like? Twenty years ago, that person would likely have been male, have entered the VA system with a baccalaureate degree, and spent much of their time behind a counter doing the grunt work of filling prescriptions.
BETHESDA, MD—Efforts in basic science at FDA have, in recent years, been “underappreciated, under resourced, and underfunded,” even though they are an essential component of the agency, FDA Commissioner Margaret Hamburg, MD told the members of FDA’s Science Board at a recent meeting.
Most Popular Stories
- Many Healthcare Providers Lose VA Retention Bonuses
- Federal Medicine Organizational Meetings — Tarred with the Same Brush?
- Despite Formulary, High-Cost Diabetes Drug Use Varies Widely Across VA Facilities
- Report Says Administration Faces Hard Choices For Veterans Programs
- Physician Overcomes TBI to Return to Active-Duty Medicine
Join Our E-Mail List